EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigations Into the Urinary Metabolite Elimination Profile of the Selective Androgen Receptor Modulator S‐23 in Studies Mimicking Contaminated Product Ingestion for Doping Control Purposes

Hana Alhalabi, Linus Korsmeier, Andreas Thomas iD, Mario Thevis iD

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Hana Alhalabi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Cologne, Germany. Hauptthemen laut MEDLINE: Doping in Sports. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium des Innern, für Bau und Heimat, Manfred Donike Institut für Dopinganalytik.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Selective androgen receptor modulators (SARMs) have repeatedly been reason of adverse analytical findings (AAFs) in routine doping controls. Among these, S‐23 has been identified in five AAFs reported in 2022. In addition to intentional doping, inadvertent exposure through contaminated dietary supplements has emerged as a significant concern, purportedly as well as evidently contributing to AAFs involving SARMs. Thus, the differentiation of inadvertent intake and intentional abuse of S‐23 is of growing relevance. This study aimed at investigating the urinary concentration profile of microdosed S‐23 and to characterize the elimination pattern. Single and multidose administration studies with 1, 10, and 50 μg of S‐23 were conducted, and collected urine samples were analyzed by LC–MS/MS following enzymatic hydrolysis and solid‐phase extraction. The analytical method was validated for a semiquantitative detection of S‐23 and characterized by a limit of detection of 1 pg/mL. A total of 18 metabolites was detected in human in vivo samples following oral administration of microdosed S‐23. Moreover, the study demonstrated that a single dose of 1 μg can be detected for an average of up to 253 h, while a single dose of 50 μg can be detected up to 544 h on average.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Doping in SportsHumansTandem Mass SpectrometryMaleLimit of DetectionReproducibility of ResultsChromatography, LiquidLinear ModelsAdultYoung AdultSubstance Abuse Detection

Stichwörter der Autor:innen

SARMsS‐23dopingmetabolismsport

Autor:innen und Institutionen

  • Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Cologne, Germany.
  • European Monitoring Center for Emerging Doping Agents (EUMoCEDA), Cologne, Germany.

ORCID-Profile: Andreas Thomas, Mario Thevis

Förderung

  • Bundesministerium des Innern, für Bau und Heimat
  • Manfred Donike Institut für Dopinganalytik

Zitieren

APA

Alhalabi, H., Korsmeier, L., Thomas, A., & Thevis, M. (2025). Investigations Into the Urinary Metabolite Elimination Profile of the Selective Androgen Receptor Modulator S‐23 in Studies Mimicking Contaminated Product Ingestion for Doping Control Purposes. Biomedical Chromatography. https://doi.org/10.1002/bmc.70090

Vancouver

Alhalabi H, Korsmeier L, Thomas A, Thevis M. Investigations Into the Urinary Metabolite Elimination Profile of the Selective Androgen Receptor Modulator S‐23 in Studies Mimicking Contaminated Product Ingestion for Doping Control Purposes. Biomedical Chromatography. 2025. doi:10.1002/bmc.70090

BibTeX
@article{Alhalabi2025,
  author = {Alhalabi, Hana and Korsmeier, Linus and Thomas, Andreas and Thevis, Mario},
  title = {Investigations Into the Urinary Metabolite Elimination Profile of the Selective Androgen Receptor Modulator S‐23 in Studies Mimicking Contaminated Product Ingestion for Doping Control Purposes},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70090}
}
Kostenlos starten →